Joshua Brumm Insider Profile
4 Followers
Joshua Brumm, CEO, Director at Crescent Biopharma, holds 281.21K shares in Crescent Biopharma (Ticker: CBIO), holds 201.27K shares in Aravive (Ticker: ARAV), holds ― shares in Kaleido Biosciences (Ticker: KLDO).
Profitable Transactions
8 out of 12 Profitable Transactions
Average Return
+13.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joshua Brumm holds in companies
Most Profitable Insider Trade
Stock:
Aravive
(ARAV)
(ARAV)
Rating:Informative Sell
Date:Jan 31, 2017 - Jan 31, 2018
Return:+86.00%
The most profitable trade made by Joshua Brumm
Joshua Brumm's Trading History
Crescent Biopharma
Jun 23, 2026
CEO, Director
Uninformative Sell
761.07K
$3.96M
Aravive
Oct 23, 2017
―
Informative Sell
3.38K
$8.05K
Kaleido Biosciences
―
See Remarks
―
―
Dyne Therapeutics
Mar 12, 2024
CEO & President, Director
Uninformative Buy
2.25M
$9.17M
Zeltiq Aesthetics
Apr 23, 2012
―
Uninformative Buy
―
$434.44K
Pharmacyclics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Joshua Brumm's performance on stock
You May Also Like
Joshua Brumm insider profile FAQ
What is the percentage of profitable transactions made by Joshua Brumm?
The percentage of profitable transactions made by Joshua Brumm is 67%.
What is the average return per transaction made by Joshua Brumm?
The average return per transaction made by Joshua Brumm is 13.60%.
What stocks does Joshua Brumm hold?
Joshua Brumm holds: CBIO, ARAV, KLDO, DYN, ZLTQ, PCYC stocks.
What was Joshua Brumm’s latest transaction?
Joshua Brumm latest transaction was an Uninformative Sell of $761.07K.
What was Joshua Brumm's most profitable transaction?
Joshua Brumm’s most profitable transaction was an Informative Sell of ARAV stock on January 31, 2017. The return on the trade was 86.00%.
What is Joshua Brumm's role in Crescent Biopharma?
Joshua Brumm's role in Crescent Biopharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.